Literature DB >> 18446354

Increased frequency of pulmonary hypertension in psoriasis patients.

Yilmaz Gunes1, Mustafa Tuncer, Omer Calka, Unal Guntekin, Necmettin Akdeniz, Hakki Simsek, Ilknur Yorgun Ozdemir.   

Abstract

Several reports have demonstrated an association between psoriasis and cardiovascular diseases such as hypertension, valvular disease and arrhythmia. However, the data is scarce. Forty-seven psoriasis patients and 20 healthy people underwent transthoracic echocardiographic examination including pulse- and tissue Doppler analysis and 24-h ambulatory electrocardiographic monitoring including heart rate variability (HRV) analysis. Patients having systemic hypertension, diabetes mellitus, history of structural or ischemic heart disease, chronic obstructive pulmonary disease and any associated systemic disease were excluded. Psoriasis Area and Severity Index (PASI) was calculated and severe psoriasis was defined in the case of history of hospitalizations for psoriasis and/or getting systemic therapy. Mean age of the patients was 35.7 +/- 12.9 years and disease duration was 123.2 +/- 84.3 (3-360) months. PASI ranged from 0.4 to 34.0 (mean +/- SD: 7.1 +/- 6.6) and 20 (42.6%) patients had severe psoriasis. There were no significant differences between psoriasis patients and control group with respect to mean values of blood pressure, body mass index, lipid profile and cardiac dimensions. However, frequency of being overweight was significantly higher in psoriasis patients (42.6 vs. 10.0%, P = 0.011). No patient had valvular disease. Mild pulmonary hypertension (PH) (30-40 mmHg) was significantly more frequent in psoriasis patients (31.9 vs. 0%, P = 0.003). Pulse wave mitral Doppler deceleration and isovolumetric relaxation times were significantly longer in psoriasis patients (195.9 +/- 29.7 vs. 191.6 +/- 14.7 ms, P = 0.002 and 91.6 +/- 14.7 vs. 79.6 +/- 10.5 ms, P = 0.001, respectively). However, frequency of diastolic dysfunction was not significantly different than the control group (8.5 vs. 0%, P = 0.309). HRV parameters and frequency of supraventricular and ventricular premature beats were not significantly different between the groups. No patient had ventricular tachycardia. Echocardiographic follow-up of psoriasis patients may be important due to possible association of PH. However, incidences of structural heart disease and arrythmia are not increased in psoriasis according to our results.

Entities:  

Mesh:

Year:  2008        PMID: 18446354     DOI: 10.1007/s00403-008-0859-9

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  5 in total

Review 1.  Lipid disturbances in psoriasis: an update.

Authors:  Aldona Pietrzak; Anna Michalak-Stoma; Grazyna Chodorowska; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

2.  Incidence of Pulmonary Arterial Hypertension in Patients with Psoriasis: A Retrospective Cohort Study.

Authors:  Young M Choi; Shannon Famenini; Jashin J Wu
Journal:  Perm J       Date:  2017

3.  Echocardiographic and electrocardiographic assessments in patients with psoriasis.

Authors:  Zeinab Aryanian; Iraj Jafaripour; Edris Kohneshin; Roghayeh Pourkia; Mohammad Taghi Hedayati Goudarzi; Soudabeh Tirgar Tabari; Azar Shirzadian Kebria; Farbod Zahedi Tajrishi; Mohammad Mostafa Ansari Ramandi
Journal:  Caspian J Intern Med       Date:  2021-03

4.  Influence of psoriasis on circulatory system function assessed in echocardiography.

Authors:  Sylwia Milaniuk; Aldona Pietrzak; Barbara Mosiewicz; Jerzy Mosiewicz; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2015-06-28       Impact factor: 3.017

5.  Concomitant Interstitial Lung Disease with Psoriasis.

Authors:  Genta Ishikawa; Sakshi Dua; Aditi Mathur; Samuel O Acquah; Mary Salvatore; Mary B Beasley; Maria L Padilla
Journal:  Can Respir J       Date:  2019-08-25       Impact factor: 2.409

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.